Yen Allen, Choi Byongsu, Inam Enobang, Yeh Austin, Lin Mu-Han, Park Chunjoo, Hrycushko Brian, Nwachukwu Chika, Albuquerque Kevin
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas.
Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.
Pract Radiat Oncol. 2023 Mar-Apr;13(2):e176-e183. doi: 10.1016/j.prro.2022.10.009. Epub 2022 Nov 7.
The standard treatment for locally advanced cervical cancer involves pelvic chemoradiation. Intensity modulated radiation therapy planning requires expansion of the cervix and uterus clinical target volume (CTV) by 1.5 to 2 cm to account for motion. With online cone beam adaptive radiation therapy (OnC-ART), interfractional movement is accounted for, which can potentially lead to smaller CTV to planned target volume (PTV) margins. In this study, we attempted to determine the optimal CTV-to-PTV margin for adequate coverage with OnC-ART and factors that can affect CTV coverage.
A retrospective cohort of 21 patients with cervical cancer treated with definitive chemoradiation was included. Nine patients treated with nonadaptive radiation had the uterocervix contoured on pretreatment cone beam computed tomography (CBCT) and end-treatment CBCTs. Anterior-posterior, lateral, and superior-inferior shifts and the average shift in all directions were calculated. A CTV-to-PTV expansion was determined and verified on a validation cohort of 12 patients treated with OnC-ART.
The average anterior-posterior, lateral, and superior-inferior shifts with standard deviation were 0.32 ± 1.55 cm, 0.12 ± 2.31 cm, and 1.67 ± 3.41 cm, respectively. A uniform 5-mm expansion around the pretreatment CTV covered 98.85% ± 1.23% of the end-treatment CTV. This 5-mm expansion was applied to our validation cohort treated with OnC-ART, and 98.39% ± 3.0% of the end-treatment CTV was covered. Time between CBCTs >30 minutes and change in bladder volume were significantly correlated to CTV coverage.
Based on our analysis, a CTV-to-PTV margin of 5 mm is adequate to encompass 98% of the CTV. A significantly reduced margin could potentially decrease the toxicities associated with radiation for patients with cervical cancer and lead to improved patient reported toxicity outcomes. We recommend physicians begin with a 5-mm margin and assess adequate coverage with image guidance during daily adaptation.
局部晚期宫颈癌的标准治疗包括盆腔放化疗。调强放射治疗计划需要将宫颈和子宫的临床靶区(CTV)扩大1.5至2厘米以考虑运动因素。采用在线锥形束自适应放射治疗(OnC-ART)时,可考虑分次间的运动,这可能会使CTV到计划靶区(PTV)的边界缩小。在本研究中,我们试图确定采用OnC-ART实现充分覆盖的最佳CTV到PTV边界以及可能影响CTV覆盖的因素。
纳入了21例接受根治性放化疗的宫颈癌患者的回顾性队列。9例接受非自适应放疗的患者在治疗前锥形束计算机断层扫描(CBCT)和治疗结束时CBCT上对子宫颈进行了轮廓勾画。计算前后、左右和上下方向的移位以及所有方向的平均移位。在12例接受OnC-ART治疗的患者的验证队列中确定并验证了CTV到PTV的扩大值。
前后、左右和上下方向的平均移位及标准差分别为0.32±1.55厘米、0.12±2.31厘米和1.67±3.41厘米。在治疗前CTV周围均匀扩大5毫米可覆盖治疗结束时CTV的98.85%±1.23%。将这5毫米的扩大值应用于我们接受OnC-ART治疗的验证队列,覆盖了治疗结束时CTV的98.39%±3.0%。CBCT之间的时间>30分钟和膀胱体积变化与CTV覆盖显著相关。
根据我们的分析,5毫米的CTV到PTV边界足以覆盖98%的CTV。显著缩小边界可能会降低宫颈癌患者放疗相关的毒性,并改善患者报告的毒性结局。我们建议医生从5毫米的边界开始,并在每日适应性调整期间通过图像引导评估是否充分覆盖。